Literature DB >> 12448000

Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.

Bence Sipos1, Dirk Weber, Hendrik Ungefroren, Holger Kalthoff, Andre Zühlsdorff, Claudia Luther, Virag Török, Günter Klöppel.   

Abstract

Angiogenesis in pancreatic ductal adenocarcinomas depends on the presence of angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) and is thought to be stimulated by hypoxia. We tested the angiogenic potential of 9 cell lines of pancreatic ductal carcinoma origin by screening mRNA and protein expression of VEGF and bFGF and the release of VEGF into culture medium under normoxic and hypoxic (5% or 0.2% O2) conditions. Angiogenic activity was determined using 2- and 3-D endothelial cell assays. Furthermore, VEGF expression and tumor vascularization were studied in human pancreatic carcinoma tissues from orthotopic xenografts and resection specimens. All cell lines expressed (mRNA, protein) and secreted VEGF, whereas bFGF was only found in 3 cell lines and was secreted into the medium in low concentrations. In addition to the dominant isoforms VEGF121,VEGF165 and VEGF189, 2 isoforms described recently, VEGF145 and VEGF183, were detected. Severe hypoxia (0.2% O2), but not moderate hypoxia (5% O2) raised VEGF mRNA expression and protein secretion in 7/9 and 5/9 cell lines, respectively. Conditioned media from 7/9, 6/9, 8/9 and 7/9 cell lines stimulated endothelial cell proliferation under normoxic (24 and 48 hr) or hypoxic (24 hr, 0.2% and 48 hr 5% O2) conditions, respectively. Conditioned media from 4/9 cell lines also induced capillary-like sprouting under normoxic conditions and from 6/9 under hypoxic (0.2% O2) conditions. In xenografted carcinoma tissues microvessel density was found not to be increased around areas of ischemic necrosis. In resected ductal carcinomas showing tumor necrosis VEGF expression and microvessel density were only increased in 3/12 and 2/13 cases, respectively. In conclusion, in vitro most pancreatic ductal carcinomas show a distinct VEGF related angiogenic potential, as demonstrated by 2- and 3-D endothelial cell proliferation, which may be promoted by severe hypoxia. Surprisingly, perinecrotic tumor areas, which are supposed to be hypoxic, only rarely showed the expected increase in microvessel density and VEGF expression. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12448000     DOI: 10.1002/ijc.10753

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

2.  Interstitial fluid flow intensity modulates endothelial sprouting in restricted Src-activated cell clusters during capillary morphogenesis.

Authors:  Rodrigo Hernández Vera; Elsa Genové; Lery Alvarez; Salvador Borrós; Roger Kamm; Douglas Lauffenburger; Carlos E Semino
Journal:  Tissue Eng Part A       Date:  2009-01       Impact factor: 3.845

Review 3.  Protein kinase D2: a versatile player in cancer biology.

Authors:  Ninel Azoitei; Mathias Cobbaut; Alexander Becher; Johan Van Lint; Thomas Seufferlein
Journal:  Oncogene       Date:  2017-12-20       Impact factor: 9.867

4.  Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.

Authors:  M Anlauf; A Perren; T Henopp; T Rudolf; N Garbrecht; A Schmitt; A Raffel; O Gimm; E Weihe; W T Knoefel; H Dralle; Ph U Heitz; P Komminoth; G Klöppel
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

5.  Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts.

Authors:  Zhi-Yong Du; Ren-Yi Qin; Wei Xia; Rui Tian; Manoj Kumar
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

6.  Differential Contributions of Actin and Myosin to the Physical Phenotypes and Invasion of Pancreatic Cancer Cells.

Authors:  Angelyn V Nguyen; Brittany Trompetto; Xing Haw Marvin Tan; Michael B Scott; Kenneth Hsueh-Heng Hu; Eric Deeds; Manish J Butte; Pei Yu Chiou; Amy C Rowat
Journal:  Cell Mol Bioeng       Date:  2019-10-31       Impact factor: 2.321

Review 7.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

Review 8.  Molecular diversity of VEGF-A as a regulator of its biological activity.

Authors:  Jeanette Woolard; Heather S Bevan; Steven J Harper; David O Bates
Journal:  Microcirculation       Date:  2009-06-01       Impact factor: 2.628

9.  VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma.

Authors:  B M Beckermann; G Kallifatidis; A Groth; D Frommhold; A Apel; J Mattern; A V Salnikov; G Moldenhauer; W Wagner; A Diehlmann; R Saffrich; M Schubert; A D Ho; N Giese; M W Büchler; H Friess; P Büchler; I Herr
Journal:  Br J Cancer       Date:  2008-07-29       Impact factor: 7.640

10.  Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2.

Authors:  Kotaro Miura; Kenjiro Kimura; Ryosuke Amano; Sadaaki Yamazoe; Go Ohira; Akihiro Murata; Kohei Nishio; Tsuyoshi Hasegawa; Masakazu Yashiro; Bunzo Nakata; Masaichi Ohira; Kosei Hirakawa
Journal:  BMC Cancer       Date:  2016-04-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.